RIB - Biotechnologies
2005
Biothérapie à l’aide d’anticorps monoclonaux anti CD-71dans le traitement des tumeurs malignes : application au mélanome métastatique de la choroïde. – MELANOMAB
Project coordination
PME (petite et moyenne entreprise)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partnership
Help of the ANR 696,719 euros
Beginning and duration of the scientific project:
- 36 Months
